ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol
Aude Lacourt,
Alain Monnereau,
Brice Amadéo,
Céline Gramond,
Sandrine Plouvier,
Jean-Yves Blay,
Jean-Michel Coindre,
Gonzague de Pinieux,
François Gouin,
Antoine Italiano,
Axel Le Cesne,
François Le Loarer,
Isabelle Pellegrin,
Nicolas Penel,
Maud Toulmonde,
Françoise Ducimetière,
A Lacourt,
B Amadéo,
C Gramond,
E Marrer,
S Plouvier,
I Baldi,
S Bara,
C Bazille,
J Y Blay,
E Bompas,
L Chaigneau,
M C Chateau,
J M Coindre,
G Coureau,
D Cupissol,
T D’Almeida,
G Defossez,
P Delafosse,
C Delcambre Lair,
G De Pinieux,
A Di Marco,
T Fabre,
F Fiorenza,
J P Ghnassia,
F Gouin,
A V Guizard,
A Italiano,
J E Kurtz,
V Lebrun-Ly,
A Le Cesne,
F Le Loarer,
L R Le Nail,
C Maynou,
G Missenard,
F Molinié,
A Monnereau,
A Moreau,
N Penel,
D Ranchère-Vince,
I Ray-Coquard,
Y M Robin,
P Terrier,
M Toulmonde,
B Tretarre,
M Velten,
A S Woronoff,
F Ducimetière,
S Mathoulin-Pélissier
Affiliations
Aude Lacourt
1 Inserm U1219 - EPICENE team, Université de Bordeaux, BordeauxCedex, Aquitaine, France
Alain Monnereau
1 Inserm U1219 - EPICENE team, Université de Bordeaux, BordeauxCedex, Aquitaine, France
Brice Amadéo
1 Inserm U1219 - EPICENE team, Université de Bordeaux, BordeauxCedex, Aquitaine, France
Céline Gramond
1 Inserm U1219 - EPICENE team, Université de Bordeaux, BordeauxCedex, Aquitaine, France
Sandrine Plouvier
4 Registre des cancers de Lille et de sa Région, Lille, France
Jean-Yves Blay
Medical Oncology, Centre Léon Bérard, Lyon, Rhône-Alpes, France
Jean-Michel Coindre
7 Department of Biopathology, Bergonie Institute, Bordeaux, Aquitaine, France
Gonzague de Pinieux
8 Service d’anatomopathologie, CHRU Tours, Tours, France
François Gouin
9 Inserm UI957, CHU Nantes, Nantes, Pays de la Loire, France
Antoine Italiano
10 Department of Medical Oncology, Institute Bergonie, Bordeaux, Aquitaine, France
Axel Le Cesne
11 Medical Oncology Department, Institut Gustave Roussy, Villejuif, France
François Le Loarer
7 Department of Biopathology, Bergonie Institute, Bordeaux, Aquitaine, France
Isabelle Pellegrin
13 Service d’Immunologie-Immunogénétique, Pôle de Biologie et Pathologie, CHU de Bordeaux, Bordeaux, Aquitaine, France
Nicolas Penel
Department of Medical Oncology, Centre Oscar Lambret and Lille University, Lille, France
Maud Toulmonde
10 Department of Medical Oncology, Institute Bergonie, Bordeaux, Aquitaine, France
Françoise Ducimetière
15 Réseau de référence sarcome, Centre Léon Bérard, Lyon, Rhône-Alpes, France
A Lacourt
1University of Bordeaux, Inserm UMR 1219 EPICENE Team, Bordeaux Population Health Research Centre, Bordeaux, France
B Amadéo
C Gramond
1Univ. Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique Equipe sante environnement, Bordeaux, France
E Marrer
S Plouvier
1 INSERM, U687, Saint-Maurice, France
I Baldi
Laboratoire Santé Travail Environnement, Université Bordeaux Segalen, Bordeaux, France
S Bara
C Bazille
J Y Blay
3 Department of Medical Oncology, Institut Bergonié, Bordeaux, France
E Bompas
Centre régional de Lutte Contre le Cancer de Nantes, Boulevard Jacques Monod - 44805 Nantes Saint Herblain Cedex, France
L Chaigneau
M C Chateau
J M Coindre
G Coureau
D Cupissol
T D’Almeida
G Defossez
P Delafosse
C Delcambre Lair
G De Pinieux
A Di Marco
T Fabre
F Fiorenza
J P Ghnassia
F Gouin
A V Guizard
A Italiano
3 Department of Medical Oncology, Institut Bergonié, Bordeaux, France
J E Kurtz
V Lebrun-Ly
A Le Cesne
F Le Loarer
L R Le Nail
C Maynou
G Missenard
F Molinié
Registre des Maladies Inflammatoires Chroniques de l’Intestin (EPIMAD), Service d’Epidémiologie et de Santé Publique, Hôpital Calmette, CHR&U de Lille, 59037 Lille Cedex, France
A Monnereau
4Centre régional de lutte contre le cancer, Institut Bergonié, Bordeaux, France
A Moreau
Institut Régional du Cancer Nantes-Atlantique (IRCNA), Biothèque, Nantes, F-44093 France
N Penel
Centre Oscar Lambret, Lille, France
D Ranchère-Vince
Centre Léon Bérard, Lyon, France
I Ray-Coquard
4 Department of Adult Medical Oncology, Centre Leon Berard and Claude Bernard University, Lyon, France
Y M Robin
P Terrier
M Toulmonde
B Tretarre
4Registre des Tumeurs de l’Hérault, EA 2415, ICM, Montpellier, France
M Velten
A S Woronoff
F Ducimetière
Centre Léon Bérard, 28 Rue Laennec, Lyon, France
S Mathoulin-Pélissier
Centre Régional de Lutte Contre le Cancer de Bordeaux, 229, Cours de l'Argonne, Bordeaux, France
IntroductionSarcomas are rare tumours of connective tissue. The exact overall incidence of sarcomas is unknown due to diagnostic difficulties and the various histological subtypes (over 80 subtypes). However, the apparent increasing incidence of sarcomas suggests environmental causes such as pesticides. Except for some specific factors (ie, ionising radiation, vinyl chloride, dioxin and genetic predispositions) the scientific knowledge on the aetiology of sarcomas is sparse and inconsistent. France is a particularly appropriate country to set up a study investigating the causes of sarcoma occurrence due to the French organisation in treatment and care of sarcoma patients, which is highly structured and revolved around national expert networks. The main objective of the ETIOlogy of SARcomas (ETIOSARC) project is to study the role of lifestyle, environmental and occupational factors in the occurrence of sarcomas among adults from a multicentric population-based case–control study.Methods and analysisCases will be all incident patients (older than 18 years) prospectively identified in 15 districts of France covered by a general population-based cancer registry and/or a reference centre in sarcoma’s patient care over a 3-year period with an inclusion start date ranging from February 2019 to January 2020 and histologically confirmed by a second review of the diagnosis. Two controls will be individually matched by sex, age (5 years group) and districts of residence and randomly selected from electoral rolls. A standardised questionnaire will be administered by a trained interviewer in order to gather information about occupational and residential history, demographic and socioeconomic characteristics and lifestyle factors. At the end of the interview, a saliva sample will be systematically proposed. This study will permit to validate or identify already suspected risk factors for sarcomas such as phenoxyherbicides, chlorophenol and to generate new hypothesis to increase our understanding about the genetic and environmental contributions in the carcinogenicity process.Ethics and disseminationThe present study is promoted by the French National Institute of Health and Medical Research (identification number C17-03). This study received National French Ethic committee (CPP Sud Méditerrannée I) approval (identification number 18-31) and French Data Protection Authority (CNIL) approval (identification number 918171). Results of this study will be published in international peer-reviewed journals. Technical appendix, statistical code and dataset will be available in the Dryad repository when collection data are completed.Trial registration numberNCT03670927.